APA

Eron J. J., Lelievre J., Kalayjian R., Slim J., Wurapa A. K., Stephens J. L., McDonald C., Cua E., Wilkin A., Schmied B., McKellar M., Cox S., Majeed S. R., Jiang S., Cheng A., Das M. & SenGupta D. (2018). Safety of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in HIV-1-infected adults with end-stage renal disease on chronic haemodialysis: an open-label, single-arm, multicentre, phase 3b trial. : The lancet. HIV.

Chicago

Eron Joseph J, Lelievre Jean-Daniel, Kalayjian Robert, Slim Jihad, Wurapa Anson K, Stephens Jeffrey L, McDonald Cheryl, Cua Eric, Wilkin Aimee, Schmied Brigitte, McKellar Mehri, Cox Stephanie, Majeed Sophia R, Jiang Shuping, Cheng Andrew, Das Moupali and SenGupta Devi. 2018. Safety of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in HIV-1-infected adults with end-stage renal disease on chronic haemodialysis: an open-label, single-arm, multicentre, phase 3b trial. : The lancet. HIV.

Harvard

Eron J. J., Lelievre J., Kalayjian R., Slim J., Wurapa A. K., Stephens J. L., McDonald C., Cua E., Wilkin A., Schmied B., McKellar M., Cox S., Majeed S. R., Jiang S., Cheng A., Das M. and SenGupta D. (2018). Safety of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in HIV-1-infected adults with end-stage renal disease on chronic haemodialysis: an open-label, single-arm, multicentre, phase 3b trial. : The lancet. HIV.

MLA

Eron Joseph J, Lelievre Jean-Daniel, Kalayjian Robert, Slim Jihad, Wurapa Anson K, Stephens Jeffrey L, McDonald Cheryl, Cua Eric, Wilkin Aimee, Schmied Brigitte, McKellar Mehri, Cox Stephanie, Majeed Sophia R, Jiang Shuping, Cheng Andrew, Das Moupali and SenGupta Devi. Safety of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in HIV-1-infected adults with end-stage renal disease on chronic haemodialysis: an open-label, single-arm, multicentre, phase 3b trial. : The lancet. HIV. 2018.